Johanna Simon, Ph.D.Principal Scientist Early Formulation Screening Service at MilliporeSigma
Johanna Simon, PhD, is a Principial Scientist in the Early Formulation Screening Service in Life Science Services at MilliporeSigma. Her work focuses on the preclinical formulation development of custom lipid nanoparticles for nucleic acid modalities. After receiving her Ph.D. in Chemistry, Johanna has continued her scientific career as a postdoctoral researcher with a focus on developing antibody-functionalized nanoparticles for targeted drug delivery in vivo. Johanna has authored 50+ peer-reviewed articles in leading journals in the field of drug delivery sciences.
Mastering Lipid Nanoparticle Formulation Development – Early Formulation Screening As Key Asset to Our Integrated CTDMO Offering, 12:20pmView Session